Uniting innovation and sustainability in pharma

GEA directs its focus toward the juncture of sustainability and innovation, igniting positive transformation across our organization and the expansive pharmaceutical sector. 

Sustainability in pharmaceuticals encompasses layers of significance. Central to this is drug manufacturing, which carries substantial environmental implications, spanning resource usage, waste generation, and emissions entailed in production, packaging, and distribution. The collective adoption of eco-conscious practices within the life sciences sector serves as a collaborative effort to confront challenges such as pollution, climate change, and the depletion of vital resources.

Embedded in this landscape is the critical challenge of resource conservation. Given the extensive raw materials, energy, and water consumed by pharmaceutical processes, the adoption of sustainable practices to curtail the use of invaluable natural resources ...

GEA's Sustainable Vision: Exemplifying Innovation
As engineers, GEA takes its responsibility to help preserve a world that’s worth living in very seriously. Machinery, equipment, and production processes are central to value creation around the world, and without striving to continuously improve them, no effective progress would be made. At the same time, sustainability is opening new horizons and significant economic opportunities for companies; the future belongs to intelligent solutions that save energy, avoid emissions, and conserve resources. This vision aligns seamlessly with GEA Group's pioneering climate strategy, committing to net-zero greenhouse gas (GHG) emissions throughout its value chain by 2040. By propelling renewable energy usage, enhancing energy efficiency, and reducing emissions, GEA leads the charge in sustainable solutions, poised as a trailblazer in various sectors.

The commitment to sustainability underpins GEA Group's foundation, enhancing its internal operations, empowering clients' objectives, and nurturing communities on a carbon-neutral trajectory. This commitment is exemplified by technologies like Continuous Manufacturing, a transformative shift in pharmaceuticals that streamlines oral solid dosage production. Addressing demands for swifter product development, cost reduction, and manufacturing flexibility, Continuous Manufacturing offers higher yields, lowered utility consumption, and waste reduction. Beyond environmental benefits, this approach also enhances product quality, drug safety, and reduces the industry's carbon footprint.

A testament to this commitment is the introduction of the "Add Better" green ecolabel, seamlessly integrating sustainability into product development. This labeling paradigm empowers customers to readily identify GEA's resource-efficient offerings, thereby contributing to emissions reduction. GEA's innovation compass, firmly oriented toward sustainability, solidifies the company's dedication to a more ecologically conscious future.